Close Menu
Home » SpeeDx, LabCorp Will Codevelop MDx Tests

SpeeDx, LabCorp Will Codevelop MDx Tests

Jan 13, 2020
|
staff reporter

NEW YORK – SpeeDx said on Monday it has agreed with Laboratory Corporation of America to codevelop diagnostic tests . The agreement focuses on assays for women's health and infectious diseases.

SpeeDx and LabCorp will work together to codevelop and introduce new molecular tests using SpeeDx's proprietary technology, the Australia-based firm said in an email. Financial terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Ah, That's What It Is

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

Billions Requested

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

What to Do

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

PNAS Papers on Heart Transplant Rejection, CAR-T Profiling, Thiopurine Toxicity Variants

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.

What's Popular?

In Business News

  1. Guardant Health Q4 Revenues Up 91 Percent

  2. Karius Raises $165M in Series B Financing Round

  3. UPDATE: Exact Sciences Offering $1B of Convertible Senior Notes

  4. Twist Bioscience Adds Sample Prep Tech to Miroculus Automation Platform

  5. Sherlock Biosciences Developing CRISPR-Based Assay for SARS-CoV-2

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.